glp-1 inhibitor for weight loss medications Weight loss with GLP-1 medicines

Individuals interested in exploring growth hormone secretagogue therapy should consult with a licensed healthcare provider to discuss whether such therapy is appropriate for their individual circumstances

Jung-Mo Ahn

Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium glucose co-transporter-2 (SGLT-2) inhibitors reduce cardiorenal outcomes

iScience 24 , 116 (2021)

Switching GLP-1s Patients or clinicians might consider switching between weight-loss medications

Hypoglycemia The use of pramlintide with insulin has been associated with an increased risk of insulin-induced severe hypoglycemia in both T1D and T2D